Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: S&P Capital IQ – STARS Reports
$127.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Neurocrine Biosciences Inc announces proposed public offering of common stock


Tuesday, 25 Feb 2014 04:00pm EST 

Neurocrine Biosciences Inc:Says it is offering to sell 7,000,000 shares of its common stock in an underwritten public offering.Says it will also grant to the underwriters a 30-day option to purchase up to an additional 1,050,000 shares of common stock.Says Jefferies LLC and J.P. Morgan Securities LLC are acting as joint book-running managers for this offering. 

Company Quote

48.44
0.12 +0.25%
4:00pm EDT